• BAE Systems raised its forecast for 2024.
  • Rolls-Royce raised its forecasts.
  • Shell exceeded expectations and buys back shares.
  • Volkswagen says it is disappointed by its H1 margin but confirms its projections for the year.
  • Daimler Truck revised downwards its sales outlook for 2024.
  • UBS filed suit against Bank of America.
  • Evonik Q3 profit in line with Q2, confirms 2024 outlook.
  • ING Groep raised its 2024 targets.
  • Vonovia still penalized by impairments.
  • Anheuser-Busch Inbev exceeds expectations in Q2, despite volumes down more sharply than expected.
  • DHL exceeds expectations in Q2.
  • Mediobanca boosts profits and buys back shares.
  • Nexi confirms its forecasts and expects the takeover to be completed by the end of 2024.
  • Calida finalizes the sale of Lafuma Mobilier.
  • Sales of Italian shoemaker Geox fall by over 9% in the first half.
  • John Wood Group extends the deadline for the Sidara takeover offer to August 9.
  • Chevron announced that the arbitration hearing in Guyana will begin in May.
  • CrowdStrike is sued by its own shareholders following a major software failure.
  • Mysterious Paramount Global suitor raises questions.
  • Reddit blocks Microsoft search engines and demands payment.
  • Boeing appoints an engineer to lead the group in a turnaround.
  • Pershing Square abandons the IPO of its US division.
  • Walt Disney to cut jobs in its TV unit, according to Bloomberg.
  • Toyota reports a 17% rise in first-quarter operating profit, in line with forecasts.
  • Otsuka to pay up to $1.1 billion to acquire Jnana Therapeutics.
  • Meta Platforms reported sales ahead of Wall Street expectations for the April-June period and a solid forecast for third-quarter sales, underlining its confidence in its ability to offset heavy investment in the development of artificial intelligence (AI). The stock gained 7.3% before the opening.
  • Qualcomm reported a sales forecast for the current quarter ahead of Wall Street expectations on Wednesday, citing solid demand for high-end smartphones and banking on the fact that more chips powering artificial intelligence (AI) will be used for device upgrades. The group nevertheless warned of the impact of trade tensions and lost 2.3% before the opening.
  • Arm Holdings reported better-than-expected sales for the April-June period on Wednesday but announced a sales forecast for the current quarter in line with Wall Street expectations. The stock lost 10.7% before the opening, punished by investors who fear that the group will not benefit from the spin-offs linked to AI.
  • Apple and Amazon gained 0.5% and 0.9% respectively in pre-market trading ahead of the publication of their respective results later in the evening.
  • Nvidia advanced by 0.6% in premarket trading on the heels of a gain of around $330 billion in market capitalization, the highest amount in a single session for a Wall Street-listed company.
  • eBay on Wednesday forecast below-consensus sales for the third quarter, indicating that demand is slowing for collectibles, luxury handbags, and watches.
  • Western Digital reported below-consensus sales on Wednesday, citing a slower-than-expected recovery for its data storage products. The stock fell by 6.2% before the opening.
  • American International Group reported a smaller-than-expected rise in second-quarter earnings, hurt by lower underwriting revenues in its general insurance unit and higher catastrophe losses.
  • MetLife reported better-than-expected earnings for its second quarter on Wednesday, thanks to a strong performance by its group benefits unit.
  • Biogen gains around 1% in pre-market trading. The laboratory raised its adjusted earnings forecast for this year to $15.75-$16.25 per share, up from $15-$16, counting on the launch of new treatments and a cost-cutting program.
  • Eli Lilly gained 2.4% in pre-market trading, as the pharmaceutical group reports positive data from a late-stage trial showing that its anti-obesity Zepbound reduces the risk of hospitalization, death, and other complications in obese adults with a common type of heart failure.
  • Moderna fell nearly 13% after lowering its sales forecast for this year to a range of $3-$3.5 billion, as the laboratory anticipates very weak sales in the EU.
  • Mobileye Global plunged 8.8% in pre-market trading, as the automotive technology specialist cuts its annual revenue forecast from a range of $1.83-$1.96 billion to $1.60-$1.68 billion.
  • Lam Research announced Wednesday that it expects September quarter sales to beat Wall Street estimates, as demand from chipmakers is expected to be supported by the development of AI. The stock nevertheless lost 2.7% before the opening.
  • Ansys on Wednesday reported above-consensus sales and earnings for the second quarter, buoyed by growing demand for its AI-powered tools and engineering software solutions.
  • Carvana announced on Wednesday that it expects above-consensus annual earnings, thanks to strong demand for its used vehicles and improved inventory management. The stock climbed 11% in pre-market trading.
  • Hess and Chevron retreat before the opening as Chevron's proposed purchase of Hess is further delayed.
  • Albemarle, the world's largest lithium producer, said on Wednesday that it would cut costs for the second time this year, and that all expenses except its dividend could be reduced. The stock lost 2.3% before the opening.
  • APA reported above-consensus second-quarter sales on Wednesday, thanks to higher oil prices.
  • Cognizant Technology Solutions raised its sales forecast for the year and reported above-consensus second-quarter earnings on Wednesday, as more companies turned to the IT services provider to digitize their operations.
  • C.H. Robinson beat Wall Street estimates for second-quarter earnings on Wednesday, boosted by its cost-containment initiatives. The stock is up nearly 8% in after-hours trading.
  • PTC forecast sales and earnings for the current quarter ahead of Wall Street estimates but reported disappointing sales for the previous quarter as corporate spending remained limited.
  • Etsy reported above-consensus sales and gross sales for the second quarter, as demand for personalized gifts continued unabated.
  • Kyndryl Holdings posted its first quarterly profit since its spin-off from IBM in 2021, helped by growth in its consulting segment and a shift towards higher-margin contracts.
  • Corteva reported above-consensus earnings on Wednesday, buoyed by high prices for its seeds.

Today's main earnings report: Apple, Amazon, Intel Corporation, Booking, ConocoPhillips, Eaton Corporation, Vertex, Regeneron, Cigna, Southern Company, MercadoLibre, Intercontinental Exchange, Ferrari, Thomson Reuters, Canadian Natural Resources, EOG Resources, Apollo Global Management, Motorola Solutions, Monster Beverage, Coinbase, Air Products, Microchip, Atlassian, Moderna, DoorDash, Prudential Financial, Shell, Anheuser-Busch Inbev, Volkswagen, BMW, Merck KGaA, London Stock Exchange, ING Groep, DHL Group, BAE Systems, Crédit Agricole, Barclays, Haleon, Rolls-Royce, Daimler Truck, Cellnex Telecom, Vonovia, ArcelorMittal, Veolia Environnement, Société Générale, Symrise, MTU Aero Engines, Next, Mediobanca, Prysmian.

The full earnings calendar is here.